Regulus Therapeutics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGLS research report →
About the company
Regulus Therapeutics Inc. , a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States.
- CEO
- Joseph P. Hagan
- IPO
- 2012
- Employees
- 34
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $564.95M
- P/E
- -9.95
- P/S
- 0.00
- P/B
- 6.02
- EV/EBITDA
- -11.49
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -95.00%
- ROIC
- -64.60%
- Revenue
- $0 · 0.00%
- Net Income
- $-46,358,000 · -54.34%
- EPS
- $-0.82 · 48.10%
- Op Income
- $-50,040,000
- FCF YoY
- -53.44%
- 52W High
- $8.35
- 52W Low
- $0.83
- 50D MA
- $7.14
- 200D MA
- $2.89
- Beta
- 0.37
- Avg Volume
- 2.16M
Get TickerSpark's AI analysis on RGLS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 25, 25 | RASTETTER WILLIAM H | other | 44,264 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 30,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 15,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 60,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 2,325 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 9,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 4,000 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 57,292 |
| Jun 25, 25 | RASTETTER WILLIAM H | sell | 4,650 |
| Jun 25, 25 | Witz Pascale | sell | 4,000 |
Our RGLS coverage
Recent articles, reports, and earnings notes.
No research on RGLS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RGLS report →Similar companies
Peers in the same neighborhood.